|
Bashkova I.B., Busalaeva E.I.
The level of awareness of beginner district therapists about the management of patients with primary osteoarthritis
|
№2 (приложение) / 2022
|
|
Nesterenko V.A., Karateev A.E.
New possibilities of local injection therapy in complex treatment of skeletal and muscular pain
|
№2 / 2022
|
|
Lila A.M., Alekseeva L.I., Taskina E.A., Kashevarova N.G.
Modern algorithm for the treatment of osteoarthritis
|
№2 / 2022
|
|
Dydykina I.S., Arutyunova E.V., Kovalenko P.S., Nikolaeva E.V.
The use of hyaluronic acid preparations in the treatment of osteoarthritis of the joints of the hands and knee joint
|
№4 / 2021
|
|
Trofimov E.A., Mazurov V.I.
Combined drug therapy of post-traumatic osteoarthritis: data from a three-year prospective study
|
№4 / 2021
|
|
Sharapova E.P., Alekseeva L.I.
Local nonsteroidal anti-inflammatory drugs in the treatment of osteoarthritis
|
№3 / 2021
|
|
Karateev A.E., Lila A.M., Alekseeva L.I.
Management of patients with diseases of the musculoskeletal system during the COVID-19 pandemic
|
№1 / 2021
|
|
Alekseeva L.I.
Analysis of the latest foreign clinical recommendations for the treatment of osteoarthritis
|
№1 / 2021
|
|
Gaydukova I.Z., Mazurov V.I.
Topical non-steroidal anti-inflammatory drugs in treatment of osteoarthritis
|
№8 / 2020
|
|
Eliseeva l.N., Kartashova S.V.
Mexidol® and mexidol® forte 250 in consecutive therapy of cognitive disorders in comorbid patients with joint pathology on the background of arterial hypertension and ischemic heart disease
|
№6 / 2020
|
|
Smolnova T.Yu., Trofimov D.Yu., Chuprynin V.D.
The role of tenascin gene (TNXB) mutation in Ellers-like phenotype formation in patients with genital prolapse
|
№6 / 2020
|
|
Pilipovich A.A., Danilov Al.B.
Osteoarthritis pain: pathogenesis and modern possibilities of therapy
|
№3 / 2020
|
Русский
